| Structure | Chemical Name | CAS | MF |
|
4-(4-METHOXYPHENYL)ISOXAZOL-5-AMINE
|
183666-47-9
|
C10H10N2O2
|
|
Isoxazolo[5,4-c]isoxazole, 3-(1,1-dimethylethyl)- (9CI)
|
183666-50-4
|
C8H10N2O2
|
|
Isoxazolo[5,4-c]isoxazole-3-carboxylic acid, ethyl ester (9CI)
|
183666-51-5
|
C7H6N2O4
|
|
4-imidazo[2,1-b][1,3]thiazol-6-ylaniline
|
183668-02-2
|
C11H9N3S
|
|
4-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-PIPERIDINE-1,4-DICARBOXYLIC ACID MONO-TERT-BUTYL ESTER
|
183673-66-7
|
C26H30N2O6
|
|
1-T-BOC-PIPERIDINE-4-SPIRO-5'-[1',3'-BIS-T-BOC]-HYDANTOIN
|
183673-68-9
|
C22H35N3O8
|
|
1-T-BOC-PIPERIDINE-4-SPIRO-5'-HYDANTOIN
|
183673-70-3
|
C12H19N3O4
|
|
4-AMINO-1-BOC-PIPERIDINE-4-CARBOXYLIC ACID
|
183673-71-4
|
C11H20N2O4
|
|
Penthiopyrad
|
183675-82-3
|
C16H20F3N3OS
|
|
2-phenylthiophen-3-amine
|
183676-85-9
|
C10H9NS
|
|
2-(4-bromophenyl)thiophen-3-amine
|
183677-02-3
|
C10H8BrNS
|
|
4-BROMOBENZENEBORONIC ACID NEOPENTYL GLYCOL ESTER
|
183677-71-6
|
C11H14BBrO2
|
|
1H-Pyrrole,2-ethyl-3,4-dimethyl-(9CI)
|
183680-94-6
|
C8H13N
|
|
1H-Pyrrole,2-ethyl-3-methyl-4-(1-methylethyl)-(9CI)
|
183680-96-8
|
C10H17N
|
|
DI-PEG-2 SOYAMINE IPDI
|
183681-06-3
|
|
|
AcetaMide, N-[2-[(4-chlorophenyl)Methyl]-4-piperidinyl]-, Monohydrochloride, trans- (9CI)
|
183683-28-5
|
C14H20Cl2N2O
|
|
ARACHIDONOYL SERINOL
|
183718-70-9
|
C23H39NO3
|
|
N-(3-hydroxyphenyl)-Arachidonoyl amide
|
183718-75-4
|
C26H37NO2
|
|
AM 404
|
183718-77-6
|
C26H37NO2
|
|
(+/-)-BMS 204352
|
183720-28-7
|
C16H10ClF4NO2
|
|
MRS 1220
|
183721-15-5
|
C21H14ClN5O2
|
|
3-bromo-4-methylbenzamide
|
183723-09-3
|
C8H8BrNO
|
|
4-(METHYLTHIO)BENZHYDROL
|
183729-63-7
|
C14H14OS
|
|
N-(4-Piperidinyl)propanamide hydrochloride
|
183732-59-4
|
C8H17ClN2O
|
|
quinuclidin-3-yl acetate (2R,3R)-2,3-dihydroxysuccinate
|
183736-31-4
|
C13H21NO8
|
|
CHCC Acid [6-Chloro-7-hydroxycouMarin-3-carboxylic acid]
|
183736-74-5
|
C10H5ClO5
|
|
Guanosine, N-[(diMethylaMino)Methylene]-2'-O-Methyl-
|
183737-04-4
|
C14H20N6O5
|
|
Benzamide, 3-formyl-N-methyl- (9CI)
|
183739-65-3
|
C9H9NO2
|
|
5-methoxyindole-1-carbaldehyde diethyl acetal
|
183741-62-0
|
C14H19NO3
|
|
TERT-BUTYL-N-(6-METHOXY-3-PYRIDYL)CARBAMATE
|
183741-80-2
|
C11H16N2O3
|
|
5-(TERT-BUTOXYCARBONYLAMINO)-2-METHOXYPYRIDINE-4-CARBOXYLIC ACID
|
183741-86-8
|
C12H16N2O5
|
|
5-AMINO-2-METHOXY-ISONICOTINIC ACID
|
183741-91-5
|
C7H8N2O3
|
|
4-Pyridinecarboxylicacid,5-amino-1,2-dihydro-2-oxo-(9CI)
|
183742-01-0
|
C6H6N2O3
|
|
4-Boc-1-Fmoc-2-piperazinecarboxylic acid
|
183742-23-6
|
C25H28N2O6
|
|
1-tert-Butyl 3-ethyl piperazine-1,3-dicarboxylate
|
183742-29-2
|
C12H22N2O4
|
|
(1,4-Dibenzyl-piperazin-2-yl)-acetic acid methyl ester
|
183742-32-7
|
C21H26N2O2
|
|
N-4-BOC-2-PIPERAZINEACETIC ACID METHYL ESTER
|
183742-33-8
|
C12H22N2O4
|
|
4-Boc-1-Fmoc-2-Piperazine acetic acid
|
183742-34-9
|
C26H30N2O6
|
|
2-fluoro-3-hydroxycyclohex-2-en-1-one
|
183742-83-8
|
C6H7FO2
|
|
1,3-Cyclohexanedione,2,2-difluoro-(9CI)
|
183742-84-9
|
C6H6F2O2
|
|
Cyclohexanone, 2,2-difluoro-3,3-dihydroxy-
|
183742-86-1
|
C6H8F2O3
|
|
1,3-Cyclopentanediol,4-(2-hydroxyethyl)-5-(hydroxymethyl)-1-methyl-,[1S-(1-alpha-,3-alpha-,4-bta-,5-bta-)]-(9CI)
|
183744-46-9
|
C9H18O4
|
|
AMYLOID BETA-PROTEIN (1-15)
|
183745-81-5
|
C78H107N25O27
|
|
AMYLOID BETA-PROTEIN (6-20)
|
183745-82-6
|
C86H119N23O23
|
|
Nepadutant
|
183747-35-5
|
C45H58N10O13
|
|
3-Piperidinecarboxylicacid,2-methyl-,methylester(9CI)
|
183786-23-4
|
C8H15NO2
|
|
Cyclopentene, 1-(3-methoxy-1-propynyl)- (9CI)
|
183786-50-7
|
C9H12O
|
|
(S)-1-aza-2-bora-2-((triMethylsilyl)Methyl)-3-oxa-4,4-diphenylbicyclo[3.3.0]octane
|
183788-23-0
|
C21H28BNOSi
|
|
12-Thiocalanolide B
|
183791-90-4
|
C22H26O4S
|
|
Carbamic acid, [(1R)-2-hydroxy-1-(methoxymethyl)ethyl]-, 1,1-dimethylethyl
|
183793-49-9
|
C9H19NO4
|
|
8-Oxabicyclo[3.2.1]octa-2,6-diene-2-carboxylicacid,(1S)-(9CI)
|
183800-06-8
|
C8H8O3
|
|
TETRAKIS(1-((4-TERT-BUTYLPHENYLSULFONYL&
|
183800-15-9
|
2C30H40N2O8RhS2
|
|
4-(TRIFLUOROMETHOXY)CINNAMIC ALDEHYDE
|
183800-94-4
|
C10H7F3O2
|
|
1H-Pyrrolo[1,2,3-de]quinoxaline-2,5(3H,6H)-dione(9CI)
|
183802-11-1
|
C10H8N2O2
|
|
5-Bromo-2-chlorophenol
|
183802-98-4
|
C6H4BrClO
|
|
5-iodo-2-MethylPhenol
|
183803-06-7
|
C7H7IO
|
|
Phenol, 5-broMo-2,4-dichloro-
|
183803-12-5
|
C6H3BrCl2O
|
|
(S)-(+)-N-(oxiranylMethyl)acetaMide
|
183805-10-9
|
C5H9NO2
|
|
Formoterol fumarate dihydrate
|
183814-30-4
|
C23H28N2O8
|
|
|
Siloxanes and Silicones, 3-(2-aminoethyl)aminopropyl methoxy, di-Me, Me methoxy, polymers with 3-(2-aminoethyl)aminopropyl Me silsesquioxanes, 3-(2-aminoethyl)aminopropyldimethoxysilyloxy- and (dimethoxymethylsilyl)oxy-terminated
|
183815-50-1
|
|
|
|
Tasmannia lanceolata, ext.
|
183815-52-3
|
|
|
|
N-Ethenylformamide homopolymer hydrolyzed, hydrochlorides
|
183815-54-5
|
|
|
ABAPERIDONE
|
183849-43-6
|
C25H25FN2O5
|
|
tert-Butyl 2-(2-methoxy-2-oxoethyl)piperazine-1-carboxylate
|
183852-65-5
|
C12H22N2O4
|
|
5-(aminomethyl)-4,6-dimethylpyridin-2-amine
|
183853-50-1
|
C8H13N3
|
|
2-AMINO-5-AMINOMETHYL-6-METHYL-PYRIDINE DIHYDROCHLORIDE
|
183853-59-0
|
C7H13Cl2N3
|
|
3-[[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-[[3-(pyrazin-2-yl carbamoyl)phenyl]methyl]-1,3-diazepan-1-yl]methyl]-N-pyrazin-2-yl-benz amide
|
183854-80-0
|
C43H40N8O5
|
|
3-[[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-3-[[3-[(5-methylpyridin-2 -yl)carbamoyl]phenyl]methyl]-2-oxo-1,3-diazepan-1-yl]methyl]-N-(5-meth ylpyridin-2-yl)benzamide
|
183854-98-0
|
C47H46N6O5
|
|
2-Piperidineaceticacid,alpha-amino-(9CI)
|
183859-35-0
|
C7H14N2O2
|
|
Piperidin-2-yl-acetic acid methyl ester, hydrochloride
|
183859-36-1
|
C13H23NO4
|
|
3-[[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-[[3-(2,2,2-triflu oroethylcarbamoyl)phenyl]methyl]-1,3-diazepan-1-yl]methyl]-N-(2,2,2-tr ifluoroethyl)benzamide
|
183860-46-0
|
C39H38F6N4O5
|
|
3-chloro-N-[(4-methoxyphenyl)methyl]aniline
|
183861-03-2
|
C14H14ClNO
|
|
2-Propen-1-amine,N-(3-pyridinylmethylene)-,(E)-(9CI)
|
183864-21-3
|
C9H10N2
|
|
2-Propen-1-amine,N-(4-pyridinylmethylene)-,(E)-(9CI)
|
183864-22-4
|
C9H10N2
|
|
1-Propen-1-amine,N-(3-pyridinylmethylene)-(9CI)
|
183864-39-3
|
C9H10N2
|
|
1-Propen-1-amine,N-(3-pyridinylmethylene)-,(Z,E)-(9CI)
|
183864-41-7
|
C9H10N2
|
|
1-Propen-1-amine,N-(4-pyridinylmethylene)-(9CI)
|
183864-43-9
|
C9H10N2
|
|
|
stefin D
|
183869-09-2
|
|
|
1,4-Benzenediamine, 2-nitro-, labeled with carbon-14 (9CI)
|
183870-67-9
|
C6H7N3O2
|
|
2-(FMoc-aMino)-5-broMobenzoic Acid
|
183871-04-7
|
C22H16BrNO4
|
|
[(2S,3S)-2-(benzyloxy)pentan-3-yl]hydrazine
|
183871-36-5
|
C30H34N2O9
|
|
2-CHLORO-6,7-DIHYDRO-5H-CYCLOPENTA[B]PYRIDINE-3-CARBOXAMIDE
|
183871-87-6
|
C9H9ClN2O
|
|
Piperazine, 1,4-bis[(trimethylsilyl)methyl]- (9CI)
|
183873-64-5
|
C12H30N2Si2
|
|
6-Oxa-2-azabicyclo[3.2.0]heptane-3,7-dione,1-(hydroxymethyl)-,(1R)-(9CI)
|
183873-86-1
|
C6H7NO4
|
|
3-Methoxy-2-(phenyl Methyl) benzoic acid
|
183874-21-7
|
C15H14O3
|
|
Phenyl 3,4,6-tris-O-(phenylmethyl)-1-thio-beta-D-galactopyranoside acetate
|
183875-28-7
|
C35H36O6S
|
|
2-Piperidinecarboxylicacid,6-oxo-,methylester,(2R)-(9CI)
|
183890-34-8
|
C7H11NO3
|
|
Benzoic acid, 3-methoxy-, propyl ester (9CI)
|
183897-90-7
|
C11H14O3
|
|
Aprepitant Impurity B Enantiomer Hydrochloride
|
183901-47-5
|
C27H25ClF7NO2
|
|
.alpha.-D-Mannopyranose, 2,3,4,6-tetrabenzoate 1-(2,2,2-trichloroethanimidate)
|
183901-63-5
|
C36H28Cl3NO10
|
|
(S)-(+)-N-TBOC-2-METHYLPIPERIDINE
|
183903-99-3
|
C11H21NO2
|
|
AcetaMide, N-[(2S)-2-(acetyloxy)-3-chloropropyl]-
|
183905-31-9
|
C7H12ClNO3
|
|
|
BIOTINYL-AMYLOID BETA-PROTEIN (1-40)
|
183906-14-1
|
C204H309N55O60S2
|
|
2-Methyl-4-aMino-1-trifluoroMethoxy-benzene
|
183945-52-0
|
C8H8F3NO
|
|
(+/-)-JASMONIC ACID-9,10-D2
|
183948-71-2
|
C12H16D2O3
|
|
(+/-)-JASMONIC ACID-9,10-D2 METHYL ESTER
|
183948-77-8
|
C13H20O3
|
|
2(3H)-Furanone, 3-acetyldihydro-3-(2-propenyl)-, (R)- (9CI)
|
183952-09-2
|
C9H12O3
|
|
Benzyl 2,3-Di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside
|
183953-29-9
|
C34H34O6
|
|
3(S)-3-Hydroxymethyl-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester
|
183958-71-6
|
C15H21NO3
|
|
FMoc-Ser(tBu)-Cys(psiMe,Mepro)-OH
|
183958-93-2
|
C28H34N2O6S
|